Mounjaro (tirzepatide) has become an established option for weight management in the United Kingdom, offering patients a proven approach to sustainable weight loss.1
Mounjaro helps curb appetite and keep you fuller for longer
Steady weight loss supported by clinical trials (around 21% on average over 18 months)
Best results come with habit change: Numan's programme combines medication with behavioral change for long-term results
All content on this page has been medically reviewed by: Hassan Thwaini, Clinical Pharmacist and Copywriter, Master of Pharmacy (MPharm) on 16 February, 2026. GPhC Registration: 2221320View profile
There’s always one question that lingers in the back of your mind when starting weight loss medication like Mounjaro: when will it start working? But rather than focusing on how to maximise results, this guide explains what typically happens over time when taking Mounjaro, from the first few weeks through to longer-term treatment.
Mounjaro begins working in the body soon after the first injection, but the effects you feel and the results you see don’t happen all at once.
Chemically speaking, tirzepatide starts influencing gut hormones involved in appetite, fullness, and blood sugar within days of it being administered. Many people notice changes in appetite or food noise before any visible weight loss.1
Visible weight loss usually follows later. In the first few weeks, changes on the scales may be small, inconsistent, or not obvious at all, and that’s expected. Clinical studies show that meaningful, sustained weight loss builds gradually over months, not days.2
* Results vary between individuals and depend on adherence, dose, and lifestyle support
| Time on Mounjaro | What's happening biologically | Typical weight change* |
|---|---|---|
| Weeks 1-2 | Appetite regulation begins | Little or no visible change |
| Weeks 3-4 | Hormone levels stabilising | ~1–2% body weight² |
| Weeks 5-8 | Dose increases for many people | ~3–6% body weight² |
| Weeks 9-12 | Appetite suppression more consistent | ~6–10% body weight² |
| 6 months | Metabolic effects established | ~10–15% body weight² |
| 12-18 months | Long-term effect | ~15–22% body weight² (dose-dependent) |
This overview shows what commonly changes at each stage of treatment. Doses may vary depending on tolerance and clinical decisions.
Month 1
The first month is mainly about adjustment. Some people might feel appetite suppression quickly, whereas others may not notice much.
| Focus | What to expect |
|---|---|
| Dose | Starting dose (usually lowest) |
| Body response | Appetite changes may begin |
| Weight | Minimal or modest loss |
| Side effects | Most likely to appear now |
Month 2
By month two, weight loss starts to become more noticeable, albeit at a gradual pace.
| Focus | What to expect |
|---|---|
| Dose | First dose increase for many |
| Body response | Hunger and fullness signals clearer |
| Weight | Gradual, steady loss begins |
| Side effects | May return briefly with dose increase |
Month 3
This is where treatment starts to feel more natural and part of your routine, with its effects ‘working’ more clearly.
| Focus | What to expect |
|---|---|
| Dose | Intermediate doses |
| Body response | Appetite more consistently reduced |
| Weight | ~6–10% total loss on average |
| Side effects | May start improving |
Months 4-6
Weight loss is gradual and your lifestyle changes slowly start forming into habits.
| Focus | What to expect |
|---|---|
| Dose | Higher maintenance doses for some |
| Body response | Stronger appetite control |
| Weight | ~10–15% total loss2 |
| Side effects | Less frequent, usually mild |
Months 6-12 onwards
Clinical trials show that the greatest results occur with longer-term use, often over a year or more.2
| Focus | What to expect |
|---|---|
| Dose | Ongoing maintenance |
| Body response | Long-term metabolic effects |
| Weight | Up to ~21%+ loss in some people2 |
| Side effects | Generally stable |
Most side effects with Mounjaro are gastrointestinal and temporary.3
Most likely to appear:3
First 2-4 weeks of treatment
After dose increases
Common early effects:3
Nausea
Diarrhoea
Constipation
Reduced appetite
Less common:3
Acid reflux
Injection-site irritation
Temporary fatigue
For most people, side effects ease as the body adapts. Serious side effects are uncommon and are monitored by clinicians throughout treatment.
Mounjaro doesn’t work overnight, and that’s a good thing. Its effects build gradually, supporting steady, clinically meaningful weight loss over months rather than weeks. Understanding the timeline helps set realistic expectations and reduces unnecessary anxiety early on. With the right medical oversight, Mounjaro offers a structured, long-term approach to treating obesity as the chronic condition it is.
Farzam K, Patel P. Tirzepatide. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–16. Available from: http://dx.doi.org/10.1056/NEJMoa2206038
Mounjaro KwikPen 10mg solution for injection in pre-filled pen. Org.uk. [accessed 5 Feb 2026] Available from: https://www.medicines.org.uk/emc/product/15484/smpc
Medically reviewed:
